"Health wise I am feeling great. I am a big supporter of trials - it allows new treatments and drugs to be brought in.”
A trial looking at cabazitaxel for prostate cancer that has started to get worse after having hormone therapy and docetaxel (CANTATA)
This trial wanted to compare the chemotherapy drugs cabazitaxel and docetaxel for prostate cancer that has spread to other parts of the body. The men had prostate cancer that started to get worse after having both hormone therapy and docetaxel.
This trial was supported by Cancer Research UK.
More about this trial
- see which treatment helps men more
- learn more about the side effects
Summary of results
This trial closed early as the researchers were unable to find enough suitable people to take part.
How to join a clinical trial
Professor Nick James
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
University of Birmingham
This is Cancer Research UK trial number CRUKE/12/031.